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Abstract Deep inhalations cause a transient relaxation of the peripheral airways smooth muscles in non-asthmatic
subjects.Ithasbeenclaimedthatthe airwayresponseto deep inhalationsmaybe different in asthmatic subjects inwhom
deep inhalations should rather cause bronchoconstriction.The aim of the present study was to find out whether deep
inhalationsdiscriminatebetweenasthmatic andnon-asthmatic subjectswithpre-constrictedairways, usingamethacho-
line provocationtestprotocolwith deep inhalations following the lastdose ofmethacholine.In164 adults, amethacholine
provocationwasperformed.Directlyafter the FEV1measurementatthehighestmetacholineconcentration, the subjects
tookone deep breath and another three deep inhalations 20 s later.Oneminute after the inhalation of the highest con-
centration FEV1 was measured twice. Thirty-three asthmatics PD20FEV1 =0.24mg (0.13^0.39) (median, 25^75th 75th
percentiles) and 131 non-asthmatics PD20FEV1 =2.05mg (0.72^10.1) participated.The mean maximal decrease in FEV1
after theprovocationtestwas 36% inthe asthmatics and 27% inthenon-asthmatics.Correspondingvalues after thedeep
inhalations were 18% in the asthmatics and 12% in the non-asthmatics. In conclusion, deep inhalations attenuate the
methacholine-inducedbronchoconstrictioninboth asthmatic andnon-asthmatic subjects.Thus, the e¡ectofdeepinha-
lations didnotdiscriminate between asthmatic andnon-asthmatic subjects.r2002 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1339, available online at http://www.idealibrary.comon
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Deep inhalations may protect against bronchoconstric-
tive stimuli and induce bronchodilation depending on
whether the deep inhalations are performed before or
after a methacholine challenge (1). We have previously
shown that an FEV1manoeuvre prior to a methacholine
challenge decrease bronchial tone for up to 6min in
healthy subjects (2).Prohibition of deep inhalation during
the methacholine challenge in normal subjects caused
excessive airwaynarrowing (3,4). Ithas alsobeen demon-
strated that deep inspirations do not prevent broncho-
constriction in asthmatic subjects (5).
Burns and coworkers proposed that the degree of
bronchodilatation following deep inhalations are related
to the relative magnitude of airway and parenchymal
hysteresis (6).They also showed that the bronchodilating
e¡ect of deep inhalations after inducedbronchoconstric-Received11February 2002, accepted in revised form 28 February 2002.
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7309897; E-mail: britt-marie.sundblad@niwl.setion is smaller in asthmatic subjects than in healthy vo-
lunteers and that deep inhalations in asthmatic patients
may even potentiate the bronchoconstriction induced
bymethacholine.
There is no clear cut^limit between asthmatic and
healthy subjectswith regard to bronchial responsiveness
to direct stimuli. There is thus a substantial overlap in
bronchial responsiveness between healthy and asthmatic
subjects.With our methacholine challenge method, it is
possible to de¢ne PC20 and PD20 in approximately 80%
of the population (7,8).The aim of the present study was
to ¢nd out whether it is possible to discriminate be-
tween asthmatic and non-asthmatic subjects with this
methacholine provocation method and by the addition
of deep inhalations performed after having induced air-
ways constrictionwithmethacholine.
SUBJECTANDSTUDYDESIGN
One hundred and sixty-four subjects (81men), mean age
41 (range 22^61) years participating in the Stockholm
part of the FinEsS-study, an epidemiological respiratory
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chial challengewithmethacholine. All subjects gave their
informed consent and the study was approved by the
ethics committee at the Karolinska Institute.
Asthmawas assessed by a validated questionnaire and
a bronchial methacholine challenge. Thirty-three sub-
jects (10men) with a mean age of 38 (range 22^55) years
were classi¢ed as having asthma. Non-asthmatic sub-
jects were divided into two groups, one with positive
skin-prick test (n=48) and one with negative skin-prick
test (n=83) (Table1).
Immediately after the end of themethacholine provo-
cation test, the subjects took one deep breath (inspira-
tion to total lung capacity) and 20 s later another three
deep breaths were performed. One minute after the
stop of the methacholine challenge FEV1was measured
twice.
METHODS
Spirometry
Vital capacity (VC) and forced expiratory volume in 1s
(FEV1) was measured with a wedge spirometer (Vitalo-
graphs, Buckingham,U.K.) according to the ATS recom-
mendations (9).
Methacoline test
Bronchial challenge with methacholine was performed
with a Sidestream jet nebulizer (Medic-Aid, Pagham,
U.K.). In the Sidestream nebulizer, a total £ow of 0.4 l/s
passed through thenebulizer.Because of theevaporative
loss, the dose of methacholine administered to the air-
ways is not identical to the weight loss of the nebulizer
content. A factor of 0.75 was used to correct for the
methacholine output (10). The nebulizate was led
through a drying devicewhere the aerosol was dried for
approximately 8 s before inhalation. With this method,
the dose of methacholine reaching the lower airways is
increased at a given methacholine concentration com-
pared with the same method performed without the
drying device (7). Inhalation time (2 s) and thereby vo-
lume (0.8 l), and number of breaths (15) were controlled
using a metronome and inhalation £ow was controlled
by the use of a back valve at the outlet of the tube.
Following the pre-challenge spirometry, the subjects
were asked not to perform deep inhalations for 5min
prior to the methacholine test. By avoiding deep inhala-
tions the apparent sensitivity to methacholine is in-
creased (2). Methacholine inhalations were performed
during1min, i.e. totally 0.5min of inhalation and 0.5min
of exhalations ateach dose-step.Exactly 6minutes lasted
between the start of the inhalations of two successive
methacholine concentrations. Subjects inhaled the dilu-
ent followed by 0.5mg/ml methacholine and the subse-quent concentrations 1, 2, 4, 8, 16, 32mg/ml (8). In
subjects with asthma lower concentrations like 0.03,
0.06, 0.125 and 0.25mg/ml were used.Only one FEV1, i.e.
one forced expiration, was allowed at each dose step. If
this measure failed, the next dose was given provided
that no symptomswere reported.
PC20FEV1and PD20FEV1were calculated as themetha-
choline concentration or the cumulated dose causing a
20% decrease in FEV1 (11). The PC/PD calculations were
performed by interpolation on a logarithmic scale of
concentration or cumulated dose of methacholine, re-
spectively. In addition, the dose^response slope (DRS)
of FEV1, was calculated by linear regression using all the
data points (FEV1 values measured at all methacholine
concentrations).The per cent change of FEV1 (initial va-
lue as the average of pre-exposure and post-diluent va-
lue) was used as dependent and cumulated dose as
independent values (12,13).
Skin-prick test
Extracts from15 common aeroallergens were tested on
both forearms: cat, dog, cow, rabbit, rat, horse, birch,
timothy, mugworth, Alternaria, cladosporium,D. pteronys-
sinus, D. farinae, D. Lephidoglyphus (ALK, Copenhagen,
Denmark) and German Cockroach (Bayer, Germany).
Reactions of 2mm in diameter were considered posi-
tive.
Questionnaire
The questionnaire was based on the Obstructive Lung
Disease in Northern Sweden Studies (OLIN) question-
naire (14) and was ¢lled in together with trained inter-
viewers.
Asthma was assessed by questions about occurrence
of respiratory symptoms like wheeze, shortness of
breath and cough together with bronchial hyperrespon-
siveness or physician-diagnosed asthma and use of asth-
ma medicine.
STATISTICS
Results are presented as mean, 95% con¢dence interval
or standard deviation (lung function) or median values,
25^75th percentiles (bronchial responsiveness). Statisti-
cal comparisons were assessed by analysis of variance
(ANOVA), student’s t-test for paired andunpaired obser-
vations (lung function) and the Mann^Whitney U-test
(bronchial responsiveness). A P-value ofo0.05 was con-
sidered signi¢cant.
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FIG. 1. Bronchial responsiveness to methacholine, PD20 and
DRS (median, 25th and 75th percentile) in asthmatic and non-
asthmatic (positive and negative skin-prick test) subjects. Med-
ianvalues are indicated inthe ¢gure.SPT = skin-prick test.
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There was a di¡erence in bronchial responsiveness to
methacholine between asthmatic and non-asthmatic
subjects (Po0.001) and between atopic and non-atopic
subjects in the non-asthma group (P=0.03) (Fig. 1).
PD20FEV1 was 2,63 (0.91^11.7)mg in the non-asthma
group with negative skin-prick test, 1.08 (0.57^4.48)mg
in the corresponding group with positive skin prick
test and 0.24 (0.13^0.39)mg in the asthma group. The
corresponding DRS values were 7.49 (1.49^21.6)%/mg
and 16.0 (4.45^34.8)%/mg in non-asthmatic subjects and
78.7 (54.1^181.0)%/mg in the asthmatic subjects.
Baseline FEV1 for all non-asthmatic subjects was 3.72
(3.59^3.86) l and 3.31 (3.09^3.53) l for the asthmatic sub-
jects (P=0.005). There was no signi¢cant di¡erence in
FEV1 between atopic and non-atopic subjects in the
non-asthmatic group (P=0.6).
The mean maximal decrease in FEV1 after methacho-
line challenge compared to baseline valuewas1.01 (0.93^
1.09) l in healthy subjects (Po0.001) and1.20 (1.02^1.38) l
in the asthmatic subjects (Po0.001). After the deep inha-
lations, the FEV1decreasewas reducedby13 (11)% in non-
asthmatics (Po0.001) and with 15 (12)% in asthmatics
(Po0.001) and this further improved with 2 and 3%, re-
spectively, in the second FEV1measurement.The reduc-
tion of the FEV1 decrease induced by deep inhalations
was almost identical in the two groups (Fig. 2).Two sub-
jects in the asthmatic group (Fig. 3) and six subjects in
the non-asthmatic group reacted with a decrease in
FEV1following deep inhalations.
DISCUSSION
In thepresent study, it has been shown that the response
to methacholine is di¡erent in asthmatic and atopic
subjects compared to healthy volunteers and that is a
great overlap between the groups. Deep inhalationsTABLE 1. Characteristics of the participating subjects as baseline
Non-asthmatic subjects
n=131
Asthmatic subjects
n=33
Neg. skin-prick test
n=83
Pos. skin-prick test
n=48
Gender, female/male 40/43 20/28 23/10
Age (years)
(range)
41.3 (23^61) 40.3 (22^61) 38.1 (22^55)
VC% of pred. value
(mean7SD)
91.3711.0 93.4712.0 92.6712.5
FEV1% of pred. value
(mean7SD)
98.9713.0 98.1711.0 93.4712.8
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FIG. 2. Changes in FEV1 after the last methacholine dose and
after deep inhalations in asthmatic (&) and non-asthmatic sub-
jectswith positive (*) and negative (*) skin-prick test (mean,
95% con¢dence interval).
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methacholine in both asthmatic and non-asthmatic sub-
jects.Deep inhalations failed to inducebronchodilatation
in only a minor number of the subjects. The ¢ndings of0
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FIG. 3. Individual FEV1 for asthmatic subjects (n=33) after the
lastmethacholinedose andafterdeepinhalations.Mean FEV1 va-
lues for asthmatic and non-asthmatic subjects are indicated in
the ¢gure.this population-based study con¢rmed previous studies.
The results are in accordance with the study by Scichi-
lone et al. (15), who found that the brochodilator e¡ect
of deep inspirations alone does not di¡erentiate asthma
from non-asthma. However, they also demonstrated
that the bronchodilatation in healthy subjects was of a
somewhatgreater order ofmagnitude than in asthmatics
and that the bronchoprotective e¡ect of deep inhalation
only was found in healthy subjects. In the present study,
where deep inhalations were performed after metha-
choline-induced bronchoconstriction, we found almost
no di¡erencebetween asthmatic andnon-asthmatic sub-
jects with regard to the FEV1 increase after the deep in-
halations.
These results suggest that bronchodilation by lung-in-
£ation operates by di¡erentmechanisms than by lung in-
£ation-induced bronchoprotection. It has been claimed
that mechanical breaking of actinomyosin bridges in air-
way smooth muscles and relaxant factors from airway
tissue may be the mechanism behind the bronchodila-
tion. Duggan et al. demonstrated that it is not the lung
volume during a deep breath but rather the increase in
transpulmonarypressure thatdetermines airwayhyster-
esis responsible for the bronchodilatation (16). On the
other hand, the mechanism behind the deep inhalation-
induced bronchoprotection has been suggested to be
stretching of airway smooth muscles that induces
changes in contractile apparatus which interact with an
activation of neural and hormonal pathways where nitric
oxide may be the major transmitter (15). This has been
suggested to make the smooth muscles more resistant
to bronchoconstrictor stimuli. It may be a defect in this
mechanism that explains the lack of deep inhalation-in-
duced bronchoprotection and the association with air-
way hyperresponsiveness in asthmatics (1).
In a previously reported study, we demonstrated that
deep inhalations before the administration of methacho-
line protected the airways from bronchoconstriction in
healthy subjects (2). Kapsali et al. demonstrated this
bronchoprotective e¡ect of deep inhalations in healthy
subjects and also the absence of this e¡ect in asthmatic
subjects even in those with mild disease (5).Thus, it has
been suggested that an intrinsic impairmentof the ability
of inspiration to stretch airway smooth muscles is a ma-
jor feature of asthma and that this is associatedwith air-
way hyperresponsiveness (3,15).However, Brusasco et al.
showed thatdeep inhalationshadno e¡ecton the in£am-
matorycells in induced sputumin asthmatic subjects (17).
The remaining bronchoconstriction after the
bronchodilatory inhalation manoeuvres tended to
be higher when the bronchoconstriction before the
bronchodilatory manoeuvres was more pronounced
(15). In that study, a limitation of the bronchodilator ef-
fect of deep inhalationswith increasing bronchoconstric-
tion was observed. In our study, we found no di¡erence
in the bronchodilator ability of deep inhalations in
EFFECTOFDEEP INHALATIONSAFTER ABRONCHIALMETHACHOLINEPROVOCATION 481healthy and asthmatic subjects, the increase in FEV1after
brochodilatation was approximately14% in both groups.
However, the asthmatics had still lower FEV1values than
healthy subjects after the deep inhalations and neither
the healthy nor the asthmatic subjects dilated the air-
ways maximally after two deep inhalations. Among the
asthmatic subjects with bronchial-hyperresponsiveness
(high FEV1 decrease after methacholine provocation),
there were both those who experienced dilatation and
constriction of airways. Results from another study
shows that the asthmatic smoothmuscle resides in a stif-
fer biological state comparedwith the stimulatedhealthy
smooth muscle and this was suggested to implicate that
healthy subjects can dilate airways after a single deep
breath (18).
It has repeatedly been shown with di¡erent provoca-
tion challenges that there is di¡erence in bronchial re-
sponsiveness between asthmatic, atopic and healthy
subjects (19,20). Our methacholine challenge has a high
sensitivity, PC20 and PD20 can be de¢ned in approxi-
mately 80% of the population. The method is not de-
signed to discriminate asthmatic from non-asthmatic
subjects but rather to discriminate between di¡erences
in bronchial responsiveness within a population.The re-
sults from this studydemonstrate that bronchial respon-
siveness inmany normal healthy subjects are the same as
in mild asthma.
In conclusion, deep inhalations attenuate the metha-
choline-induced bronchoconstriction in both asthmatic
and non-asthmatic subjects and deep inhalations at the
endof themethacholine challenge couldnotdiscriminate
between asthmatic and non-asthmatic subjects.
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